Abstract
Twenty-eight patients with histologically confirmed cirrhosis were followed for up to 3.8 years after [14C]aminopyrine breath analysis. Survival rates were calculated by life-table method and outcome analyzed by log rank test. A normal breath test score was associated with a higher probability of survival than a low score, although the difference was not statistically significant. A normal serum albumin was a better predictor of outcome. Survival curves constructed according to the results of breath analysis and serum albumin differed in that the former appeared to predict early survival and the latter late survival. For this reason, data were reanalyzed by subjects' results for both tests. A normal breath test score and a normal serum albumin was associated with a significantly higher probability of survival than an abnormal result for either test.
Similar content being viewed by others
References
Galambos J: The cirrhoses.In Gastroenterology, 3rd ed. HL Bockus (ed) Philadelphia, WB Saunders, 1976, pp 401–403
Sherlock S: Diseases of the Liver and Biliary System, 5th ed. Oxford, Blackwell Scientific Publications, 1975, pp 455–456
Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP: Portal hypertension, size of eosophageal varices and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 79:1139–1144, 1980
Winkel P, Juhl E, Tygstrup N, and The Copenhagen Study Group for Liver Diseases: The prognostic value of clinical and laboratory data in patients with cirrhosis. Scand J Gastroenterol Suppl 7:181–187, 1970
Tygstrup N: The galactose elimination capacity in relation to clinical and laboratory findings in patients with cirrhosis. Acta Med Scand 175:291–300, 1964
Lindskov J: The quantitative liver function as measured by the galactose elimination capacity. II Prognostic value and changes during disease in patients with cirrhosis. Acta Med Scand 212:303–308, 1982
Hepner GW, Chopra IJ: Serum thyroid hormone levels in patients with liver disease. Arch Intern Med 139:1117–1120, 1979
Branch RA: Drugs as indicators of hepatic function. Hepatology 2:97–105, 1982
Saunders B, Wright N, Lewis KO: Predicting outcome of paracetamol poisoning by using [14C]aminopyrine breath test. Br Med J 280:279–280, 1980
Henry DA, Sharpe G, Chaplain S, Cartwright S, Kitchingman G, Bell GD, Langman MJS: The [14C]aminopyrine breath test a comparison of different forms of analysis. Br J Clin Pharmacol 8:539–545, 1979
Pauwels S, Geubel AP, Dive C, Beckers C: Breath14CO2 after intravenous administration of [14C]aminopyrine in liver diseases. Dig Dis Sci 27:49–56, 1982
Noordhoek J, Dees J, Savenije-Chapel EM, Wilson JHP: Output of14CO2 in breath after oral administration of [methyl-14C]aminopyrine in hepatitis, cirrhosis and hepatic bilharziasis: Its relationship to aminopyrine pharmacokinetics. Eur J Clin Pharmacol 13:223–229, 1978
Henry DA, MacDonald IA, Kitchingman G, Bell GD, Langman MJS: Cimetidine and ranitidine: Comparison of effects on hepatic drug metabolism. Br Med J 281:1–6, 1980
Hepner GW, Vesell ES: Quantitative assessment of hepatic function by breath analysis after oral administration of [14C]aminopyrine. Ann Intern Med 83:632–638, 1974
Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35: 1–39, 1977
Burnstein AV, Galambos JT: [14C]Aminopyrine breath test in chronic liver disease. Preliminary diagnostic implications. Dig Dis Sci 26:1078–1093, 1981
Morelli A, Narducci F, Pelli MA, Farroni F, Vedovelli A: The relationship between aminopyrine breath test and severity of liver disease in cirrhosis. Am J Gastroenterol 76:110–113, 1981
Galizzi J, Long RG, Billing BH, Sherlock S: Assessment of the [14C]aminopyrine breath test in liver disease. Gut 19:40–45, 1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Henry, D.A., Kitchingman, G. & Langman, M.J.S. [14C]aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis. Digest Dis Sci 30, 813–818 (1985). https://doi.org/10.1007/BF01309509
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01309509